Thomas Delong

Thomas Delong

Assistant Professor
Pharmaceutical Sciences
  • Skaggs School of Pharmacy and Pharmaceutical Sciences

Email Address:

Primary Phone: 303-724-0448

Recent Publications

Office Location:

Pharmacy and Pharmaceutical Sciences Building (V20)
Second Floor Room 2116

Research Interests:

  • Mass spectrometry
  • Post-translational modifications
  • Autoantigen discovery in autoimmune diseases
  • T cell immunology
  • Pathogenesis of Type 1 Diabetes

Representative publications:

Identification of Hybrid Insulin Peptides (HIPs) in Mouse and Human Islets by Mass Spectrometry. J Proteome Res. 2019 Mar 1;18(3):814-825. doi: 10.1021/acs.jproteome.8b00875. Epub 2019 Jan 3. Aaron Wiles T, Powell R, Michel CR, Scott Beard K1, Hohenstein A, Bradley B, Reisdorph N, Haskins K, Delong T.

Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science. 2016 Feb 12;351(6274):711-4. doi: 10.1126/science.aad2791. Delong T, Wiles TA, Baker RL, Bradley B, Barbour G, Reisdorph R, Armstrong M, Powell RL, Reisdorph N, Kumar N, Elso CM, DeNicola M, Bottino R, Powers AC, Harlan DM, Kent SC, Mannering SI, Haskins K

Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells. Diabetes. 2011 Sep;60(9):2325-30. doi: 10.2337/db11-0288. Epub 2011 Jul 6. Delong T, Baker RL, Reisdorph N, Reisdorph R, Powell RL, Armstrong M, Barbour G, Bradley B, Haskins K

Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol. 2010 Mar;11(3):225-31. doi: 10.1038/ni.1844. Epub 2010 Feb 7. Stadinski BD, Delong T, Reisdorph N, Reisdorph R, Powell RL, Armstrong M, Piganelli JD, Barbour G, Bradley B, Crawford F, Marrack P, Mahata SK, Kappler JW, Haskins K.